IDT Australia Ltd
ASX:IDT

Watchlist Manager
IDT Australia Ltd Logo
IDT Australia Ltd
ASX:IDT
Watchlist
Price: 0.095 AUD Market Closed
Market Cap: 40.8m AUD

Operating Margin
IDT Australia Ltd

-27.4%
Current
-64%
Average
6.6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-27.4%
=
Operating Profit
-5.2m
/
Revenue
18.9m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
IDT Australia Ltd
ASX:IDT
40.8m AUD
-27%
US
Eli Lilly and Co
NYSE:LLY
735.9B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
404B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
45%
CH
Roche Holding AG
SIX:ROG
202.1B CHF
33%
CH
Novartis AG
SIX:NOVN
178.4B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
160.5B GBP
24%
US
Merck & Co Inc
NYSE:MRK
205.3B USD
34%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
11%
US
Pfizer Inc
NYSE:PFE
142.9B USD
27%

IDT Australia Ltd
Glance View

Market Cap
40.8m AUD
Industry
Pharmaceuticals

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. The firm specializes in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging and pharmacy services. The company provides services for new drug development and scale-up, commercial active drug manufacture as well as a various oral and injectable finished drug dose forms. Its sterile manufacturing suite is designed to liquid fill and lyophilise a range of sterile pharmaceutical and biopharmaceutical drug products. Its current goods manufacturing practices (cGMP) facilities manufactures a range of medicinal cannabis products for local and international markets.

IDT Intrinsic Value
0.188 AUD
Undervaluation 49%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-27.4%
=
Operating Profit
-5.2m
/
Revenue
18.9m
What is the Operating Margin of IDT Australia Ltd?

Based on IDT Australia Ltd's most recent financial statements, the company has Operating Margin of -27.4%.

Back to Top